CL2011002862A1 - Uso de perhexilina o una sal farmaceuticamente aceptable de la misma para preparar un medicamento util en el tratamiento de miocardiopatia hipertrofica (mch). - Google Patents
Uso de perhexilina o una sal farmaceuticamente aceptable de la misma para preparar un medicamento util en el tratamiento de miocardiopatia hipertrofica (mch).Info
- Publication number
- CL2011002862A1 CL2011002862A1 CL2011002862A CL2011002862A CL2011002862A1 CL 2011002862 A1 CL2011002862 A1 CL 2011002862A1 CL 2011002862 A CL2011002862 A CL 2011002862A CL 2011002862 A CL2011002862 A CL 2011002862A CL 2011002862 A1 CL2011002862 A1 CL 2011002862A1
- Authority
- CL
- Chile
- Prior art keywords
- treatment
- perhexiline
- hcm
- prepare
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Perhexilina para el tratamiento de miocardiopatía hipertrófica y programa de tratamiento que implica el uso conjunto de perhexilina con uno o más compuestos diferentes que son ventajosos en el tratamiento de dicha enfermedad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0908193.6A GB0908193D0 (en) | 2009-05-13 | 2009-05-13 | Treatment of disease state |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011002862A1 true CL2011002862A1 (es) | 2012-07-20 |
Family
ID=40833905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011002862A CL2011002862A1 (es) | 2009-05-13 | 2011-11-14 | Uso de perhexilina o una sal farmaceuticamente aceptable de la misma para preparar un medicamento util en el tratamiento de miocardiopatia hipertrofica (mch). |
Country Status (14)
Country | Link |
---|---|
US (2) | US8697728B2 (es) |
EP (1) | EP2429525A1 (es) |
JP (2) | JP2012526792A (es) |
CN (2) | CN107296810A (es) |
AU (1) | AU2010247120B2 (es) |
BR (1) | BRPI1007779A2 (es) |
CA (1) | CA2799087A1 (es) |
CL (1) | CL2011002862A1 (es) |
GB (1) | GB0908193D0 (es) |
IL (1) | IL216288A0 (es) |
MX (1) | MX338099B (es) |
NZ (1) | NZ597031A (es) |
WO (1) | WO2010131033A1 (es) |
ZA (1) | ZA201109184B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0405381D0 (en) | 2004-03-10 | 2004-04-21 | Univ Wales Medicine | A method and means for treating heart failure |
GB0908193D0 (en) | 2009-05-13 | 2009-06-24 | Albright Patents | Treatment of disease state |
EP2432470A1 (en) | 2009-05-20 | 2012-03-28 | Heart Metabolics Limited | Treatment of heart failure with normal ejection fraction |
EP2892529A4 (en) * | 2012-09-05 | 2016-01-20 | Adelaide Res &Innovation Pty Ltd | USES OF (-) - PERHEXILINE |
US9340443B2 (en) | 2012-12-13 | 2016-05-17 | Corning Incorporated | Bulk annealing of glass sheets |
TN2015000553A1 (en) * | 2013-06-21 | 2017-04-06 | Myokardia Inc | Pyrimidinedione compounds against cardiac conditions |
KR20160145062A (ko) | 2014-04-09 | 2016-12-19 | 코닝 인코포레이티드 | 디바이스 변경된 기판 물품 및 제조 방법 |
JP2018524201A (ja) | 2015-05-19 | 2018-08-30 | コーニング インコーポレイテッド | シートをキャリアと結合するための物品および方法 |
JP7106276B2 (ja) | 2015-06-26 | 2022-07-26 | コーニング インコーポレイテッド | シート及び担体を有する物品及び方法 |
WO2017153850A1 (en) * | 2016-03-07 | 2017-09-14 | Heart Metabolics Limited | Perhexiline dosing regimens for use in the treatment of hypertrophic cardiomyopathy |
TW201825623A (zh) | 2016-08-30 | 2018-07-16 | 美商康寧公司 | 用於片材接合的矽氧烷電漿聚合物 |
TWI810161B (zh) | 2016-08-31 | 2023-08-01 | 美商康寧公司 | 具以可控制式黏結的薄片之製品及製作其之方法 |
CN111615567B (zh) | 2017-12-15 | 2023-04-14 | 康宁股份有限公司 | 用于处理基板的方法和用于制备包括粘合片材的制品的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN380695A0 (en) | 1995-06-23 | 1995-07-20 | Queen Elizabeth Hospital, The | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
US20030162824A1 (en) | 2001-11-12 | 2003-08-28 | Krul Elaine S. | Methods of treating or preventing a cardiovascular condition using a cyclooxygenase-1 inhibitor |
CL2004000366A1 (es) | 2003-02-26 | 2005-01-07 | Pharmacia Corp Sa Organizada B | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. |
GB0405381D0 (en) * | 2004-03-10 | 2004-04-21 | Univ Wales Medicine | A method and means for treating heart failure |
AU2005230811A1 (en) | 2004-04-06 | 2005-10-20 | Angiogenetics Sweden Ab | Angiogenesis-affecting compounds and methods of use thereof |
GB0723100D0 (en) | 2007-11-23 | 2008-01-02 | Heart Metabolics Ltd | Treatment of HFnEF |
GB0908193D0 (en) | 2009-05-13 | 2009-06-24 | Albright Patents | Treatment of disease state |
EP2432470A1 (en) | 2009-05-20 | 2012-03-28 | Heart Metabolics Limited | Treatment of heart failure with normal ejection fraction |
-
2009
- 2009-05-13 GB GBGB0908193.6A patent/GB0908193D0/en not_active Ceased
-
2010
- 2010-05-11 AU AU2010247120A patent/AU2010247120B2/en not_active Ceased
- 2010-05-11 CA CA2799087A patent/CA2799087A1/en not_active Abandoned
- 2010-05-11 BR BRPI1007779A patent/BRPI1007779A2/pt not_active IP Right Cessation
- 2010-05-11 CN CN201710190805.0A patent/CN107296810A/zh active Pending
- 2010-05-11 EP EP10720191A patent/EP2429525A1/en not_active Withdrawn
- 2010-05-11 NZ NZ597031A patent/NZ597031A/en not_active IP Right Cessation
- 2010-05-11 JP JP2012510371A patent/JP2012526792A/ja active Pending
- 2010-05-11 CN CN2010800324443A patent/CN102481297A/zh active Pending
- 2010-05-11 WO PCT/GB2010/050770 patent/WO2010131033A1/en active Application Filing
- 2010-05-11 MX MX2011012131A patent/MX338099B/es active IP Right Grant
- 2010-05-11 US US13/319,986 patent/US8697728B2/en not_active Expired - Fee Related
-
2011
- 2011-11-10 IL IL216288A patent/IL216288A0/en unknown
- 2011-11-14 CL CL2011002862A patent/CL2011002862A1/es unknown
- 2011-12-13 ZA ZA2011/09184A patent/ZA201109184B/en unknown
-
2014
- 2014-02-21 US US14/186,554 patent/US20140194466A1/en not_active Abandoned
-
2015
- 2015-08-13 JP JP2015159914A patent/JP2015232019A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2011012131A (es) | 2012-03-07 |
BRPI1007779A2 (pt) | 2016-02-23 |
CA2799087A1 (en) | 2010-11-18 |
AU2010247120A1 (en) | 2012-01-19 |
ZA201109184B (en) | 2012-08-29 |
JP2012526792A (ja) | 2012-11-01 |
EP2429525A1 (en) | 2012-03-21 |
CN107296810A (zh) | 2017-10-27 |
WO2010131033A1 (en) | 2010-11-18 |
US8697728B2 (en) | 2014-04-15 |
IL216288A0 (en) | 2012-01-31 |
AU2010247120B2 (en) | 2016-06-02 |
MX338099B (es) | 2016-04-01 |
JP2015232019A (ja) | 2015-12-24 |
CN102481297A (zh) | 2012-05-30 |
NZ597031A (en) | 2014-04-30 |
US20120122925A1 (en) | 2012-05-17 |
GB0908193D0 (en) | 2009-06-24 |
US20140194466A1 (en) | 2014-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011002862A1 (es) | Uso de perhexilina o una sal farmaceuticamente aceptable de la misma para preparar un medicamento util en el tratamiento de miocardiopatia hipertrofica (mch). | |
CL2007003726A1 (es) | Anticuerpos anti-receptor del factor del crecimiento similar a la insulina i (igf-ir); composicion farmaceutica que lo contiene; y su uso para tratar el cancer. | |
BR112013032717A2 (pt) | coagonistas do receptor de glucagon/glp-1 | |
ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
SV2009002858A (es) | Nueva forma polimorfica y la forma amorfa de 5- cloro-n-([(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il]-metil)-2-tiofenocarboxamida | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
CO6541566A2 (es) | Composición farmacéutica que comprende un agonista de glp -1 y metionina | |
BRPI0818193A2 (pt) | composto, sal farmacêuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto | |
CL2008000791A1 (es) | Compuestos derivados de 2-amino-5-(4-difluorometoxi-fenil)-5-fenil-imidazolidin-4-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la actividad bace excesiva, tales como enferm | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
CL2012002125A1 (es) | Metodo para la purificacion de anticuerpos de una mezcla de proteina en un biorreactor; unidad operacional que se utiliza en el metodo antes descrito. | |
CR20110221A (es) | Terapia de combinación con péptidos epoxicetonas peptídicas | |
CL2009000394A1 (es) | Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
CL2013002053A1 (es) | Compuestos derivados de heterociclicos, antagonistas del receptor de glucagon; composicion farmaceutica que lo comprende y su uso en el tratamiento de diabetes y enfermedades metabolicas. pct | |
BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
CR20120177A (es) | Nuevos compuestos de espiropiperidina y el uso farmacéutico del mismo para el tratamiento de diabetes | |
PE20140978A1 (es) | Composicion farmaceutica solida que contiene amlodipina y losartan y el proceso para producirla | |
CL2011000214A1 (es) | Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona. | |
GT201200164A (es) | "nuevos compuestos de espiropiperidina" | |
AR077638A1 (es) | Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad | |
CL2007000345A1 (es) | Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de uno o mas agentes terapeuticos y una cantidad mejoradora de la absorcion intestinal de uno o mas agonistas de receptores de zonulina/zot; y uso de la composicion para tratar la diabetes. | |
CL2012002437A1 (es) | Uso de antiinflamatorio no esteroide (aine) o una sal farmacologicamente aceptable del mismo para preparar un medicamento util para el tratamiento de enfermedades renales cronicas en gatos. | |
EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
CL2013000881A1 (es) | Combinaciones farmacéuticas que comprenden un componente (a) que corresponden a compuestos derivados de difenilurea omega-carboxiaril-sustituidos, (b) compuestos derivados de n-(2-arilamino)arilsulfonamida y (c) que son uno o más agentes farmaceuticos adicionales; y su uso en el tratamiento del cancer | |
BRPI1013988A2 (pt) | composto, composição farmacêutica , e, uso de um composto ou um sal farmacologicamente aceitável do mesmo |